From Name:
From Email:
To Name:
To Email:

Optional Message:

Advocacy Alert: Tell Sen. Wyden That Taxpayers Already Receive a Return on Investment

from AUTM

In a recent letter to NIH Director Dr. Francis S. Collins, Sen. Ron Wyden, D-Ore., has implored the NIH to reconsider its policies to require consideration of the public interest in the pricing of drugs developed under NIH collaborative research and development agreements (CRADA) with industry. Read AUTM President Sean Flanigan's blog on the subject here.

AUTM is urging members to meet with their federal relations colleagues and write to Sen. Wyden. Send your own letter, or customize this template letter. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063